The survey on cellular and engineered tissue therapies in Europe in 2009

Tissue Engineering - Part A

Volumn 17, Issue 17-18, 2011, Pages 2221-2230

  Martin, Ivan ^a   Baldomero, Helen ^a   Bocelli Tyndall, Chiara ^b   Slaper Cortenbach, Ineke ^c   Passweg, Jakob ^a   Tyndall, Alan ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Felix Platter Spital   (Switzerland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; STEM CELLS; SURVEYS; TISSUE;

3D SCAFFOLDS; ALLOGENEIC CELLS; AUTOIMMUNE DISEASE; AUTOLOGOUS CELL; CELL TYPES; CELLULAR THERAPY; CHONDROCYTES; DERMAL FIBROBLASTS; ENGINEERED TISSUES; HEMATOPOIETIC STEM CELLS; KERATINOCYTES; NEUROLOGICAL DISEASE;

SCAFFOLDS (BIOLOGY);

ARTICLE; BIOLOGICAL THERAPY; BONE MARROW TRANSPLANTATION; EUROPE; FEMALE; HUMAN; MALE; STATISTICS; TISSUE ENGINEERING;

BONE MARROW TRANSPLANTATION; EUROPE; FEMALE; HUMANS; MALE; TISSUE ENGINEERING; TISSUE THERAPY;

EID: 80051685628     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0131     Document Type: Review

References (21)

1. Martin, I., Baldomero, H., Tyndall, A., Niederwieser, D., and Gratwohl, A. A survey on cellular and engineered tissue therapies in Europe in 2008. Tissue Eng A 16, 2419, 2010.
2. Gratwohl, A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 8, 197, 1991.
3. Gratwohl, A., Baldomero, H., Horisberger, B., Schmid, C., Passweg, J., and Urbano-Ispizua, A. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 100, 2374, 2002.
4. Gratwohl, A., Baldomero, H., Schwendener, A., Gratwohl, M., Apperley, J., Niederwieser, D., Frauendorfer, K., and Joint Accreditation Committee of the International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation; European Leukemia Net. Predictability of hematopoietic stem cell transplantation rates. Haematologica 92, 1679, 2007.
5. Gratwohl, A., Baldomero, H., Schwendener, A., Rocha, V., Apperley, J., Frauendorfer, K., and Niederwieser, D. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 43, 275, 2009.
6. Menasché, P. Cell therapy for peripheral arterial disease. Curr Opin Mol Ther 12, 538, 2010.
7. Tyndall, A., and Uccelli, A. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. Bone Marrow Transplant 43, 821, 2009.
8. Pasquini, M.C., Pirog, S., Baldomero, H., Sobocinski, K., Keating, A., Hare, J., Loper, K., Laughlin,M., Horwitz, E., and Heslop,H. Cellular therapy for regenerativemedicine: activity in the US during 2008. ISCT 2010 meeting in Philadelphia. www.cibmtr.org/Meetings/Materials/WorkingCommittees/Documents/ Cellular%20Therapies/2011/2011CellularTher apiesAgenda.pdf
9. Mohyeddin Bonab, M., Yazdanbakhsh, S., Lotfi, J., Alimoghaddom, K., Talebian, F., Hooshmand, F., Ghavamzadeh, A., and Nikbin, B. Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. Iran J Immunol 4, 50, 2007.
10. Christopeit, M., Schendel, M., Fö ll, J., Mü ller, L.P., Keysser, G., and Behre, G. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia 22, 1062, 2008.
11. Liang, J., Zhang, H., Hua, B.,Wang, H.,Wang, J., Han, Z., and Sun, L. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler 15, 644, 2009.
12. Riordan, N.H., Ichim, T.E., Min, W.P., Wang, H., Solano, F., Lara, F., Alfaro, M., Rodriguez, J.P., Harman, R.J., Patel, A.N., Murphy, M.P., Lee, R.R., and Minev, B. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 7, 29, 2009.
13. Garcia-Olmo, D., Herreros, D., Pascual, I., Pascual, J.A., Del-Valle, E., Zorrilla, J., De-La-Quintana, P., Garcia-Arranz, M., and Pascual, M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52, 79, 2009.
14. Nevskaya, T., Ananieva, L., Bykovskaia, S., Eremin, I., Karandashov, E., Khrennikov, J., Mach, E., Zaprjagaeva, M., Guseva, N., and Nassonov, E. Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis. Rheumatology 48, 61, 2009.
15. Liang, J., Zhang, H., Hua, B., Wang, H., Lu, L., Shi, S., Hou, Y., Zeng, X., Gilkeson, G.S., and Sun, L. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 69, 1423, 2010.
16. Sun, L., Wang, D., Liang, J., Zhang, H., Feng, X., Wang, H., Hua, B., Liu, B., Ye, S., Hu, X., Xu, W., Zeng, X., Hou, Y., Gilkeson, G.S., Silver, R.M., Lu, L., and Shi, S. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 62, 2467, 2010.
17. Carrion, F., Nova, E., Ruiz, C., Diaz, F., Inostroza, C., Rojo, D., Mö nckeberg, G., and Figueroa, F.E. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus 19, 317, 2010.
18. Liang, J., Gu, F., Wang, H., Hua, B., Hou, Y., Shi, S., Lu, L., and Sun, L. Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol 6, 486, 2010.
19. Duijvestein, M., Vos, A.C., Roelofs, H., Wildenberg, M.E., Wendrich, B.B., Verspaget, H.W., Kooy-Winkelaar, E.M., Koning, F., Zwaginga, J.J., Fidder, H.H., Verhaar, A.P., Fibbe, W.E., van den Brink, G.R., and Hommes, D.W. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 59, 1662, 2010.
20. Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A., Gowda-Kurkalli, B., Gomori, J.M., Kassis, I., Bulte, J.W., Petrou, P., Ben-Hur, T., Abramsky, O., and Slavin, S. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 67, 1187, 2010.
21. Yamout, B., Hourani, R., Salti, H., Barada, W., El-Hajj, T., Al-Kutoubi, A., Herlopian, A., Baz, E.K., Mahfouz, R., Khalil-Hamdan, R., Kreidieh, N.M., El-Sabban, M., and Bazarbachi, A. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J Neuroimmunol 227, 185, 2010.